ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,631.22
      0.28%
      US Tech 100
      19,842.40
      -0.02%
      Dow Jones
      40,211.72
      0.53%
      Brent Oil
      83.725
      -0.73%
      Bitcoin
      63,170.57
      -2.59%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Passage Bio Inc (PASG)

      7. Passage Bio Inc (PASG) News

      PASG

      Passage Bio (PASG)

      Passage Bio Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:PASG
      DateTimeSourceHeadlineSymbolCompany
      11/13/20237:00AMGlobeNewswire Inc.Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business HighlightsNASDAQ:PASGPassage Bio Inc
      10/30/20237:00AMGlobeNewswire Inc.Passage Bio to Present at Guggenheim’s 5th Annual Inflammation, Neurology & Immunology ConferenceNASDAQ:PASGPassage Bio Inc
      10/20/20234:30PMGlobeNewswire Inc.Passage Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PASGPassage Bio Inc
      09/25/20237:00AMGlobeNewswire Inc.Passage Bio to Present at Chardan’s 7th Annual Genetic Medicines ConferenceNASDAQ:PASGPassage Bio Inc
      09/01/20234:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
      08/07/20237:18AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PASGPassage Bio Inc
      08/07/20237:15AMGlobeNewswire Inc.Passage Bio Reports Second Quarter 2023 Financial Results and Provides Recent Business HighlightsNASDAQ:PASGPassage Bio Inc
      08/07/20237:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
      08/07/20237:00AMGlobeNewswire Inc.Passage Bio Announces Promising Interim Clinical Data from First Eight Patients with GM1 Gangliosidosis in Imagine-1 StudyNASDAQ:PASGPassage Bio Inc
      08/01/20234:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PASGPassage Bio Inc
      08/01/20237:00AMGlobeNewswire Inc.Passage Bio to Participate in Upcoming Investor ConferencesNASDAQ:PASGPassage Bio Inc
      07/31/20235:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PASGPassage Bio Inc
      07/31/20235:05PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PASGPassage Bio Inc
      07/31/20237:00AMGlobeNewswire Inc.Passage Bio Welcomes Dolan Sondhi, Ph.D. to Board Of DirectorsNASDAQ:PASGPassage Bio Inc
      07/31/20237:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
      07/28/20236:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PASGPassage Bio Inc
      07/28/20236:33PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PASGPassage Bio Inc
      07/20/20237:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
      06/29/20234:43PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PASGPassage Bio Inc
      06/29/20234:37PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PASGPassage Bio Inc
      06/15/202310:29AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PASGPassage Bio Inc
      06/05/20237:00AMGlobeNewswire Inc.Passage Bio to Present at Goldman Sachs 44th Annual Global Healthcare ConferenceNASDAQ:PASGPassage Bio Inc
      05/26/20234:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PASGPassage Bio Inc
      05/26/20234:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PASGPassage Bio Inc
      05/26/20234:34PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PASGPassage Bio Inc
      05/26/20234:29PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PASGPassage Bio Inc
      05/26/20234:27PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PASGPassage Bio Inc
      05/11/20237:13AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PASGPassage Bio Inc
      05/11/20237:00AMGlobeNewswire Inc.Passage Bio Reports First Quarter 2023 Financial Results and Provides Recent Business HighlightsNASDAQ:PASGPassage Bio Inc
      05/04/20237:00AMGlobeNewswire Inc.Passage Bio Announces Recipient of Second Annual Tachi Yamada Scholarship AwardNASDAQ:PASGPassage Bio Inc
       Showing the most relevant articles for your search:NASDAQ:PASG

      Your Recent History

      NASDAQ
      PCCT
      Perception Capital Corpo...
      Delayed Upgrade Clock